Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
This structure supports consistent safety standards and accountability across every visit.
Most adults who have taken GLP-1 drugs say they took them to treat a chronic condition including diabetes or heart disease (62%), while about four in ten say they took them primarily to lose weight
By exerting both central and peripheral metabolic regulatory effects, tirzepatide has substantially narrowed the gap between pharmacological and surgical weight loss, representing a significant milestone in the advancement of multi-receptor agonist therapies for obesity [108]
Researchers studying the emerging field of triple agonism and glucagon's role in metabolic regulation may prefer retatrutide, the most novel compound of the three
Bottom Line for Illinois : If you meet the FPA criteria (most experienced PMHNPs do), you can prescribe weight-loss medications independently
